Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with chronic kidney disease (stage 3–5), meaning their kidneys have been functioning at a reduced level for at least three months
- People for whom a doctor has decided, as part of their normal care, that starting a water tablet called furosemide is appropriate
- People who are willing to take part and have signed a consent form agreeing to participate
Who may not be able to join:
- People who are already taking furosemide
- People who have a liver disease that causes a build-up of bilirubin (a yellow substance) in the body
- People who are already receiving any form of kidney replacement therapy, such as peritoneal dialysis or haemodialysis
- People who have end-stage kidney failure and whose kidneys no longer produce any urine
- People who are starting other new medications at the same time as furosemide that could interfere with how certain waste products are processed or carried in the blood (confirm with trial site)
- People who are legally considered unable to make their own decisions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karin GF Gerritsen, MD, PhD, UMC Utrecht
Phone: +31-887557375
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Plasma levels of the PBUT indoxyl sulfate; Plasma levels of the PBUT p-cresyl sulfate; Plasma levels of the PBUT indole-3-acetic acid; Plasma levels of the PBUT kynurenic acid; Plasma levels of the PBUT L-kynurenine; Plasma levels of the PBUT hippuric acid; Plasma levels of the PBUT p-cresyl glucuronide
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.